[Cu(L)(1H-1,2,4-triazole)]NO3 (3) (HL = (E)-N'-((2-hydroxynaphthalen-1-yl)methylene)benzohydrazide) are synthesized and characterized. All the Cu(Ⅱ) complexes are assessed for their in vitro anticancer properties against a panel of cancer cells. An MTT assay revealed that these Cu(Ⅱ) complexes exhibited greater anticancer activity toward several tumor cell types than the HL ligand or cisplatin. Interestingly
三种芳香酰Cu Cu(Ⅱ)络合物[Cu(L)(H 2 O)2 ] NO 3 •0.5H 2 O(1),[Cu(L)(
吲唑)(NO 3)](2)和[Cu合成并表征了(L)(1 H -
1,2,4-三唑)] NO 3(3)(HL =(E)-N '-((2-羟基
萘-1-基)亚甲基)苯并酰
肼。对所有Cu(Ⅱ)配合物进行了体外评估针对一组癌细胞的抗癌特性。M
TT分析表明,这些
铜(Ⅱ)配合物对几种肿瘤细胞的抗癌活性均高于HL
配体或
顺铂。有趣的是,观察到混合
配体的Cu(Ⅱ)配合物2和3显示出比配合物1更高的抗癌活性。流式细胞仪,
荧光成像和蛋白质印迹分析表明,复合物3可以诱导活性氧介导的凋亡
细胞死亡。而且,复合物3在3D肿瘤球体模型中表现出明显的抑制作用。